Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

5 Nov 2013 07:00

RNS Number : 1717S
Wilmington Group Plc
05 November 2013
 



5 November 2013

 

Wilmington Group plc

 

Interim Management Statement

 

 

Wilmington Group plc ("Wilmington" or "the Group"), the provider of Information, Compliance and Education to professional markets presents its Interim Management Statement for the period from 1 July 2013, based on the results for the three months ended 30 September 2013 with comments reflecting trading to date. This statement is also being made at the Group's Annual General Meeting being held today.

 

Trading UpdateGroup revenue during the three months ended 30 September 2013 was as expected marginally up on the same period in 2012, with revenues from acquisitions offset by planned disposals and discontinued marginal activities.

 

Pensions & Insurance: This division continues to deliver strong revenue and contribution growth and during the period high margins have been maintained. Inese, the provider of Spanish language subscription based publications, events and online services which was acquired in March 2013, has had a solid start to the new financial year.

 

Banking & Compliance: AMT which delivers most of its revenue and contribution during the summer months has delivered good revenue and contribution in line with our expectations, with a particularly strong performance from its graduate programmes in New York. ICT (compliance training) has continued to secure major in-house training assignments from International Banks and has a strong pipeline of projects into next year. The integration of Compliance Week, a provider of subscription based publications, events and online services which was acquired in August 2013, is progressing as planned, including the successful launch of the first Compliance Week event in Europe.

 

Healthcare: The strong performance reported by APM in France during 2013 has continued. Binley's revenues remain under pressure but overall profit contribution from the division has been maintained due to good cost control. The integration of NHiS, a provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies, which was combined with the smaller equivalent Binley's operation has progressed well.

Legal: The Legal division has continued to show a decline in turnover, reflecting planned disposals and the further scaling back of some course programmes as demand for CPD courses in the busiest time of the training year was weaker than expected. However, this revenue decline is offset to a large degree by the more flexible cost base and the continued strong performance from Bond Solon.

Business Intelligence:  As anticipated, revenue is down on the same period in the prior year, reflecting discontinued activities as a result of planned disposals and the expected decline in legacy publishing as we continue to transition from print to digital. However, contribution is in line with expectations and prior year.

 

Accountancy: As previously highlighted at the time of the full year results in September 2013, we are seeing some constraint to revenue with a decline in training revenues during the seasonally quieter first quarter. This is also reflected in the division's overall contribution due to the operational gearing of the business. We continue to invest in technical and marketing support for accountancy firms including a new responsive web platform which was launched during the period.

The Group's cash position remains robust. Net debt as at 30 September was £39.2m reflecting the acquisition of Compliance Week for £7.2m which was offset by the Group's continued strong cash generation. On 30 October 2013 a surplus freehold property was sold for £700,000 in cash and will be used to further reduce the Group's net indebtedness.

 

OutlookAt the end of the first quarter the financial performance is on track to support our expectations for the full year. July and August are typically the quietest trading months for most of the Group's businesses, the exception is AMT which delivers a significant proportion of its annual profit contribution during the first quarter. The overall trading background has not changed significantly since the full year 2013 results announcement except Legal which has had a poor end to the Legal CPD year.

 

The Group continues to invest in new technology and product development with a focus on delivering our anticipated returns from recent strategic acquisitions.

-End-

 

 

For further information, please contact:

 

Wilmington Group Plc

Charles Brady, Chief Executive

Tony Foye, Finance Director

 

FTI Consulting

Charles Palmer 

020 7422 6800

 

 

 

020 7831 3113

 

 

Notes to Editors

 

Wilmington Group plc is one of the UK's leading providers of Information, Compliance and Education for professional business markets. The Group provides business intelligence, information, training, education, events and support services for a variety of markets including the accountancy, banking, charities, financial services, healthcare, insurance, legal, and pensions sectors. Capitalised at approximately £183 million, Wilmington floated on the London Stock Exchange in 1995.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGGCUGUPWGMC
Date   Source Headline
8th Jul 20193:54 pmRNSHolding(s) in Company
4th Jul 20197:00 amRNSExtension of debt facility
1st Jul 20195:11 pmRNSTotal Voting Rights
28th Jun 20197:00 amRNSWilmington plc Pre-close Trading Update
10th Jun 20194:41 pmRNSSecond Price Monitoring Extn
10th Jun 20194:35 pmRNSPrice Monitoring Extension
3rd Jun 20197:00 amRNSTotal Voting Rights
17th May 201912:13 pmRNSHolding(s) in Company
17th May 20199:21 amRNSHolding(s) in Company
16th May 20197:00 amRNSAppointment of Mark Milner as CEO
8th May 20197:00 amRNSChange of Company Secretary
3rd May 201911:18 amRNSDirector Declaration
1st May 20197:00 amRNSTotal Voting Rights
2nd Apr 20192:20 pmRNSTotal Voting Rights
1st Apr 20197:00 amRNSSAYE and Director/PDMR Shareholding
1st Mar 201911:00 amRNSHolding(s) in Company
1st Mar 201910:58 amRNSTotal Voting Rights
21st Feb 20197:00 amRNSResults for the six months ended 31 December 2018
14th Feb 201910:19 amRNSDirectorate Change Update
1st Feb 20193:53 pmRNSTotal Voting Rights
28th Jan 20194:44 pmRNSHolding(s) in Company
16th Jan 20197:00 amRNSDirectorate Change
2nd Jan 201910:33 amRNSTotal Voting Rights
14th Dec 20184:43 pmRNSNotification of Interim Results
3rd Dec 20187:00 amRNSTotal Voting Rights
14th Nov 20187:00 amRNSNew Joint Venture Agreement
1st Nov 20182:07 pmRNSResult of AGM
1st Nov 20187:00 amRNSTotal Voting Rights
1st Nov 20187:00 amRNSAGM Statement and Q1 Trading Update
17th Oct 20185:13 pmRNSHolding(s) in Company
1st Oct 20185:44 pmRNSDirector/PDMR Shareholding
1st Oct 201810:18 amRNSTotal Voting Rights
25th Sep 201812:29 pmRNSHolding(s) in Company
21st Sep 20183:13 pmRNSDirector/PDMR Shareholding
20th Sep 20183:19 pmRNSDirector/PDMR Shareholding
19th Sep 20182:12 pmRNSShare Awards
12th Sep 20187:00 amRNSFinancial results for the year ended 30 June 2018
3rd Sep 20189:00 amRNSTotal Voting Rights
28th Aug 201810:39 amRNSHolding(s) in Company
1st Aug 20189:00 amRNSTotal Voting Rights
19th Jul 20187:00 amRNSSale of ICP Credit Reporting Business
10th Jul 20184:24 pmRNSHolding(s) in Company
10th Jul 20184:19 pmRNSHolding(s) in Company
9th Jul 20182:23 pmRNSHolding(s) in Company
6th Jul 20187:00 amRNSTrading Statement
2nd Jul 201810:29 amRNSVoting Rights and Capital
1st Jun 20189:00 amRNSTotal Voting Rights
9th May 20187:00 amRNSCapital Markets Day
1st May 20187:00 amRNSTotal Voting Rights
3rd Apr 20187:00 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.